Skip to content
Aussie8 – Lifestyle
Author:
Kazia Therapeutics Ltd
Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer
July 28, 2026